Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
Perennial shrub native to Oceania. It contains kavapirones (styryl-lactones), chalcones, cinnamates and sterols. The dried rhizome is used.It has anxiolytic, hypnotic and myorelaxant properties. Oral administration. (Fitoterapia.net, IARC 2016 p 117-140, WHO 2002 p231-245)
As of the last update we found no published data on its excretion in breast milk.
May cause serious adverse effects (Posadzki 2013) and is possibly carcinogenic (group 2B) in humans. (IARC 2016 p 137)
The European Medicines Agency (EMA) has recommended the withdrawal from the market of products containing Kava, due to a high risk of hepatotoxicity causing fulminant hepatic failure. (Ballotin 2018, NLM 2018, Bunchorntavakul 2013, NLM 2012, Chitturi 2008)
The Spanish Ministry of Health and Consumption includes it in the list of plants whose sale to the public is prohibited or restricted due to its toxicity. (MSC 2004)